Osher Lifelong Learning Institute
Treatment and Prevention of Alzheimer’s Disease: Hope on the Horizon is Here Today!
Speaker
Professor Howard Feldman, M.D., FRCP(C)
Coordinator
Jeff Sakihara
There has been a rapid transformational evolution
of measures that can identify Alzheimer’s disease
neuropathology, enabling new insights and
approaches in both asymptomatic persons and those
affected by symptoms of the disease. There have
also been recent breakthroughs in therapy involving
the use of anti-amyloid monoclonal antibodies that
can lower amyloid beta proteins in persons in the
early stages of disease. With greater recognition of
risk and protective factors for brain health, very real
possibilities exist for lifestyle intervention to optimize
brain aging, as well as lower dementia risk.
of measures that can identify Alzheimer’s disease
neuropathology, enabling new insights and
approaches in both asymptomatic persons and those
affected by symptoms of the disease. There have
also been recent breakthroughs in therapy involving
the use of anti-amyloid monoclonal antibodies that
can lower amyloid beta proteins in persons in the
early stages of disease. With greater recognition of
risk and protective factors for brain health, very real
possibilities exist for lifestyle intervention to optimize
brain aging, as well as lower dementia risk.
Speaker Bio
Presenter: Dr. Howard Feldman is Professor of
Neuroscience at UC San Diego and Director of
the Alzheimer’s Disease Cooperative Study and
holds the inaugural Epstein Family Chancellor’s
Chair. He has specialized expertise in the care and
research of cognitive disorders associated with
aging and neurodegenerative dementias. The
recipient of many awards, he received his medical
degree from McGill University in Quebec, Canada.
Neuroscience at UC San Diego and Director of
the Alzheimer’s Disease Cooperative Study and
holds the inaugural Epstein Family Chancellor’s
Chair. He has specialized expertise in the care and
research of cognitive disorders associated with
aging and neurodegenerative dementias. The
recipient of many awards, he received his medical
degree from McGill University in Quebec, Canada.
05